For: | López-Campos F, González-San Segundo C, Conde-Moreno AJ, Couñago F. Metastatic hormone-sensitive prostate cancer: How should it be treated? World J Clin Oncol 2021; 12(2): 43-49 [PMID: 33680871 DOI: 10.5306/wjco.v12.i2.43] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v12/i2/43.htm |
Number | Citing Articles |
1 |
A. B. Reiss, U. Saeedullah, D. J. Grossfeld, A. D. Glass, A. Pinkhasov, A. E. Katz. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function. Clinical and Translational Oncology 2021; 24(5): 733 doi: 10.1007/s12094-021-02727-1
|
2 |
Xingyu Xiong, Shi Qiu, Xianyanling Yi, Hang Xu, Haoran Lei, Dazhou Liao, Shengjiang Bai, Ge Peng, Qiang Wei, Jianzhong Ai, Lu Yang. Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systematic review. Urologic Oncology: Seminars and Original Investigations 2022; 40(1): 4.e19 doi: 10.1016/j.urolonc.2021.08.014
|